Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression

Patrycja K. Thompson, Edward L. Y. Chen, Renée F. de Pooter, Catherine Frelin, Walter K. Vogel, Christina R. Lee, Thomas Venables, Divya K. Shah, Norman N. Iscove, Mark Leid, Michele K. Anderson and Juan Carlos Zúñiga-Pflücker
J Immunol July 1, 2022, 209 (1) 77-92; DOI: https://doi.org/10.4049/jimmunol.2100366
Patrycja K. Thompson
*Department of Immunology, University of Toronto, Toronto, Ontario, Canada;
†Sunnybrook Research Institute, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward L. Y. Chen
*Department of Immunology, University of Toronto, Toronto, Ontario, Canada;
†Sunnybrook Research Institute, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edward L. Y. Chen
Renée F. de Pooter
*Department of Immunology, University of Toronto, Toronto, Ontario, Canada;
†Sunnybrook Research Institute, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Frelin
‡Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter K. Vogel
§Department of Pharmaceutical Sciences, Oregon State University, Corvallis, OR; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Walter K. Vogel
Christina R. Lee
†Sunnybrook Research Institute, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Venables
¶The Scripps-Florida Research Institute, Jupiter, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Divya K. Shah
*Department of Immunology, University of Toronto, Toronto, Ontario, Canada;
†Sunnybrook Research Institute, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norman N. Iscove
*Department of Immunology, University of Toronto, Toronto, Ontario, Canada;
‡Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Leid
§Department of Pharmaceutical Sciences, Oregon State University, Corvallis, OR; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Leid
Michele K. Anderson
*Department of Immunology, University of Toronto, Toronto, Ontario, Canada;
†Sunnybrook Research Institute, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michele K. Anderson
Juan Carlos Zúñiga-Pflücker
*Department of Immunology, University of Toronto, Toronto, Ontario, Canada;
†Sunnybrook Research Institute, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan Carlos Zúñiga-Pflücker
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Key Points

  • GATA3 is required for a Notch-induced program of T lineage differentiation.

  • GATA3 is required for Bcl11b expression, and together they repress the Cdkn2 locus.

  • Dysregulated Cdkn2 expression leads to apoptosis of early T lineage cells.

Abstract

The zinc-finger transcription factor GATA-3 plays a crucial role during early T cell development and also dictates later T cell differentiation outcomes. However, its role and collaboration with the Notch signaling pathway in the induction of T lineage specification and commitment have not been fully elucidated. We show that GATA-3 deficiency in mouse hematopoietic progenitors results in an early block in T cell development despite the presence of Notch signals, with a failure to upregulate Bcl11b expression, leading to a diversion along a myeloid, but not a B cell, lineage fate. GATA-3 deficiency in the presence of Notch signaling results in the apoptosis of early T lineage cells, as seen with inhibition of CDK4/6 (cyclin-dependent kinases 4 and 6) function, and dysregulated cyclin-dependent kinase inhibitor 2b (Cdkn2b) expression. We also show that GATA-3 induces Bcl11b, and together with Bcl11b represses Cdkn2b expression; however, loss of Cdkn2b failed to rescue the developmental block of GATA-3–deficient T cell progenitor. Our findings provide a signaling and transcriptional network by which the T lineage program in response to Notch signals is realized.

Footnotes

  • This work was supported by Canadian Institutes of Health Research Grants MOP-119538 and FDN-154332 (to J.C.Z.-P.), funds from the Canadian Cancer Society Research Institute (to J.C.Z.-P.), and a by a Canadian Institutes for Health Research Banting and Best Doctoral Research Award (to P.K.T.). J.C.Z.-P. is a recipient of a Canada Research Chair in Developmental Immunology.

  • The microarray data, ChIP-seq data, and detailed analytical methods presented in this article have been submitted to Gene Expression Omnibus under accession numbers GSE199279 and GSE59826.

  • Juan Carlos Zúñiga-Pflücker is a Distinguished Fellow of AAI.

  • The online version of this article contains supplemental material.

  • Abbreviations used in this article:

    CDK4/6
    cyclin-dependent kinases 4 and 6
    Cdkn2b
    cyclin-dependent kinase inhibitor 2b
    ChIP
    chromatin immunoprecipitation
    DN
    double-negative
    DP
    double-positive
    ESC
    embryonic stem cell
    ETP
    early thymic progenitor
    Lin
    lineage (marker)
    LSK
    Lin−, Sca-1+, and CD117 (Kit)+
    OP9-C
    OP9-control
    poly(I:C)
    polyinosinic:polycytidylic acid
    qPCR
    quantitative real-time PCR
    RES
    regulatory element in DNA sequence
    TSS
    transcription start site

  • Received April 19, 2021.
  • Accepted April 28, 2022.
  • Copyright © 2022 by The American Association of Immunologists, Inc.
View Full Text

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

In this issue

The Journal of Immunology: 209 (1)
The Journal of Immunology
Vol. 209, Issue 1
1 Jul 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression
Patrycja K. Thompson, Edward L. Y. Chen, Renée F. de Pooter, Catherine Frelin, Walter K. Vogel, Christina R. Lee, Thomas Venables, Divya K. Shah, Norman N. Iscove, Mark Leid, Michele K. Anderson, Juan Carlos Zúñiga-Pflücker
The Journal of Immunology July 1, 2022, 209 (1) 77-92; DOI: 10.4049/jimmunol.2100366

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression
Patrycja K. Thompson, Edward L. Y. Chen, Renée F. de Pooter, Catherine Frelin, Walter K. Vogel, Christina R. Lee, Thomas Venables, Divya K. Shah, Norman N. Iscove, Mark Leid, Michele K. Anderson, Juan Carlos Zúñiga-Pflücker
The Journal of Immunology July 1, 2022, 209 (1) 77-92; DOI: 10.4049/jimmunol.2100366
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • APRIL Drives a Coordinated but Diverse Response as a Foundation for Plasma Cell Longevity
  • NPAT Supports CD8+ Immature Single-Positive Thymocyte Proliferation and Thymic Development
  • Delta-like 4–Derived Notch Signals Differentially Regulate Thymic Generation of Skin-Homing CCR10+NK1.1+ Innate Lymphoid Cells at Neonatal and Adult Stages
Show more IMMUNE SYSTEM DEVELOPMENT

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606